UPDATE 1-Genmab and J&J's cancer drug set for blockbuster sales this year
February 22, 2017 at 15:04 PM EST
COPENHAGEN, Feb 22 (Reuters) - Danish biotech drugmaker Genmab expects sales of Darzalex, used to fight cancer in bone marrow, to surpass $1 billion this year to become a blockbuster drug, the company said on Wednesday.
